publication venue for
- Imaging the translocator protein 18 kDa within cognitive control and declarative memory circuits in virally-suppressed people with HIV. 2024
- Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves. 38:1597-1600. 2024
- Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1. 38:217-222. 2024
- Pilot imaging of the colony stimulating factor 1 receptor in the brains of virally-suppressed individuals with HIV. 37:1419-1424. 2023
- Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people living with HIV. 36:F17-F26. 2022
- Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV. 36:1465-1468. 2022
- Risk of adverse coronavirus disease 2019 outcomes for people living with HIV. 35:F1-F10. 2021
- Challenges to achieving and maintaining viral suppression among children living with HIV. 34:687-697. 2020
- Unconditional cash transfers for clinical and economic outcomes among HIV-affected Ugandan households. 32:2023-2031. 2018
- Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapy. 32:1661-1667. 2018
- Benefits and risks of rapid initiation of antiretroviral therapy. 32:17-23. 2018
- Adherence to HIV postexposure prophylaxis. 28:2721-2727. 2014
- Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease. 28:1791-1796. 2014
- Cognitive and language outcomes in HIV-uninfected infants exposed to combined antiretroviral therapy in utero and through extended breast-feeding. 28:S323-S330. 2014
- Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy. 27:1403-1412. 2013
- Intimate partner violence is associated with incident HIV infection in women in Uganda. 27:1331-1338. 2013
- Adverse events associated with nevirapine use in pregnancy. 27:1135-1143. 2013
- Engaging men in HIV treatment and care. 27:851-851. 2013
- Male sex and the risk of mortality among individuals enrolled in antiretroviral therapy programs in Africa. 27:417-425. 2013
- Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries. 26:2039-2052. 2012
- Aging with HIV in Africa. 26:S1-S5. 2012
- Association between older age and adverse outcomes on antiretroviral therapy. 26:S31-S37. 2012
- HIV and Africa's elderly. 26:S85-S91. 2012
- The prognostic value of baseline CD4+ cell count beyond 6 months of antiretroviral therapy in HIV-positive patients in a resource-limited setting. 26:1425-1429. 2012
- Political lessons from the global HIV/AIDS response to inform a rapid noncommunicable disease response. 26:1171-1173. 2012
- Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings. 26:929-938. 2012
- Safety of task-shifting for male medical circumcision. 26:559-566. 2012
- Endometrial epithelial cell response to semen from HIV-infected men during different stages of infection is distinct and can drive HIV-1-long terminal repeat. 26:27-36. 2012
- Periodic presumptive treatment of curable sexually transmitted infections among sex workers: a systematic review. 26:437-445. 2012
- A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune. 25:731-739. 2011
- Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohort. 25:777-786. 2011
- Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda. 25:851-855. 2011
- Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy. 25:701-705. 2011
- Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV–HCV coinfection before and after antiretroviral therapy. 24:1857-1865. 2010
- Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts. 24:1461-1470. 2010
- The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening. 24:1307-1313. 2010
- Ensuring sustainable antiretroviral provision during economic crises. 24:341-343. 2010
- Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda. 22:2493-2499. 2008
- Stable pattern of HIV-1 subtype C Gag-specific T-cell responses coincides with slow rate of CD4 T-cell decline in HIV-infected Ethiopians. 21:369-372. 2007
- Barriers to participating in an HIV vaccine trial. 18:2235-2242. 2004
- The impact of syndromic treatment of sexually transmitted diseases on genital shedding of HIV-1. 18:781-785. 2004
- HIV prevalence in 72 000 urban and rural male army recruits, Ethiopia. 17:1835-1840. 2003
- Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians. 17:815-819. 2003
- Evidence of changes in sexual behaviours among male factory workers in Ethiopia. 17:223-231. 2003
- HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani. 14:921-929. 2000
- HIV viral load and response to antileishmanial chemotherapy in co-infected patients. 13:1921-1925. 1999
- Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. 13:1115-1122. 1999
- Reply. 13:1150-1150. 1999
- Predictors of survival and eradication of Mycobacterium avium complex bacteremia (MAC) in AIDS patients in the Canadian Randomized MAC Treatment Trial. 13:575-582. 1999
- Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. 13:501-507. 1999
- CD8+ T cell-mediated suppression of HIV long terminal repeat-driven gene expression is not associated with improved clinical status. 11:581-586. 1997
- CD8+ T-cell-mediated suppression of HIV-1 long terminal repeat-driven gene expression is not modulated by the CC chemokines RANTES, macrophage inflammatory protein (MIP)-1α and MIP-1β. 11:575-580. 1997
- HIV infection in female prostitutes from Benin: association with symptomatic but not asymptomatic gonococcal or chlamydial infections.. 11:685-686. 1997
- Cytotoxic T-lymphocytes from HIV-infected individuals recognize an activation-dependent, non-polymorphic molecule on uninfected CD4+ lymphocytes. 10:247-254. 1996
- Dideoxyinosine-associated nephrotoxicity. 7:131-131. 1993
- The influence of lymphocyte counts and disease progression on circulating and inducible anti-HIV-1 cytotoxic T-cell activity in HIV-1-infected subjects. 6:1085-1094. 1992
- Low-dose dapsone prophylaxis of Pneumocystis carinii pneumonia in AIDS and AIDS-related complex. 4:1145-1148. 1990
- HIV isolation and antigen detection in infected individuals and their seronegative sexual partners. 2:107-112. 1988